- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Delaware Medical Marijuana Laws & Regulations
In 2011, the Delaware state legislature approved Senate Bill 17, the Delaware Medical Marijuana Act making it legal for a patient with a Delaware registry identification card to use cannabis for medical purposes. Patients with a valid registry identification card are protected from arrest so long as they have no more than six (6) ounces of usable cannabis and are otherwise in compliance with state law. Police officers may verify an ID card's validity with the Department of Health and Social Services (DHSS). Designated caregivers with registry ID cards are similarly protected insofar as they are assisting their designated patient or patients.
Qualifying patients and caregivers are protected under Delaware law from discrimination affecting their employment, education, housing, parental rights, or medical care, including transplants. Employers are not required to allow patients to be impaired at work or to allow the possession of marijuana at a workplace. Insurance providers would not have to cover medical marijuana.
Threats against state officials and employees from the U.S. Attorney that caused the governor to suspend indefinitely the implementation of the dispensary licensing program mandated by the law. Nonetheless, Delaware lawmakers adopted regulations for the Medical Marijuana Program in 2012.
The state Division of Public Health is now accepting patient applications for registry ID cards through the Health Systems Protection office. You can contact the program by phone at (302) 744-4749 or by email at [email protected]. Passage of the law created an affirmative defense for up to six (6) ounces of medicine under certain conditions until 75 days after the state began accepting patient and caregiver registration applications on July 1, 2012.
Initial draft regulations were issued by the Delaware Department of Health and Social Services (DHSS) in April 2012; however, before the regulation were finalized, the program was suspended by Governor Jack Markell as the result of a letter sent to him from the U.S. Attorney for Delaware threatening legal action against the state. In August 2013, Gov. Markell lifted the suspension and Rita Landgraf, secretary of DHSS, said she expected to propose new draft regulations on October 1, 2013. The Department finalized regulations in January 2014.
In 2015, 3 legislative updates were made to the program. SB 7 made technical changes to the oversight commission, while SB 138 authorized the research studies to be conducted to the states. The most notable change was SB 90, which allows for pediatric access to cannabis extract oils with less than 7% THC.
SB 138 (2015) Research Authorization
SB 90 (2015) Pediatric Access
SB 7 (2015) - Oversight Committee
Delaware Medical Marijuana Act